Improving safety and health in Zambian boarding schools by reducing HIV-related stigma.
A total school approach using safeguarding to address HIV-related stigma and discrimination in boarding schools in Zambia
This study is working to make Zambian boarding schools friendlier and safer for everyone by helping students and staff understand and support those living with HIV, so that everyone can feel accepted and healthy, no matter their status.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Southern California NIH-funded |
| Lab location | 1 site (Los Angeles, UNITED STATES) |
| Project ID | NIH-11002859 on NIH RePORTER |
What this research studies
This research aims to create a safer and more supportive environment in Zambian boarding schools by addressing HIV-related stigma and discrimination. It involves collaborating with students, teachers, and staff to develop and implement training programs that promote understanding and acceptance of individuals living with HIV. The project will evaluate the effectiveness of these interventions in reducing stigma and improving health outcomes for all students, regardless of their HIV status. By fostering a culture of care and respect, the research seeks to mitigate the negative impacts of stigma on health and well-being.
Who could benefit from this research
Good fit: Ideal candidates for participation include children aged 0-11 years, particularly those attending boarding schools in Zambia.
Not a fit: Patients who are not enrolled in boarding schools or are outside the age range of 0-11 years may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved health outcomes and a safer school environment for children affected by HIV.
How similar studies have performed: Previous research has shown that stigma reduction interventions can significantly improve health outcomes in similar educational settings, indicating a promising approach.
Where this research is happening
Los Angeles, UNITED STATES
- University of Southern California — Los Angeles, United States (Active)
Researchers
- Principal investigator: Ferguson, Laura — University of Southern California
- Study coordinator: Ferguson, Laura
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.